Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Merck
Cantor Fitzgerald
Accenture
Moodys
Argus Health
Farmers Insurance
Johnson and Johnson
Healthtrust

Generated: January 23, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021591

« Back to Dashboard

NDA 021591 describes RIOMET, which is a drug marketed by Sun Pharm Inds Ltd and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the RIOMET profile page.

The generic ingredient in RIOMET is metformin hydrochloride. There are forty-nine drug master file entries for this compound. One hundred and eleven suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.
Summary for 021591
Tradename:RIOMET
Applicant:Sun Pharm Inds Ltd
Ingredient:metformin hydrochloride
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 021591
Medical Subject Heading (MeSH) Categories for 021591
Suppliers and Packaging for NDA: 021591
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIOMET metformin hydrochloride SOLUTION;ORAL 021591 NDA Sun Pharmaceutical Industries, Inc. 10631-206 10631-206-01 118 mL in 1 BOTTLE (10631-206-01)
RIOMET metformin hydrochloride SOLUTION;ORAL 021591 NDA Sun Pharmaceutical Industries, Inc. 10631-206 10631-206-02 473 mL in 1 BOTTLE (10631-206-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength500MG/5ML
Approval Date:Sep 11, 2003TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Sep 14, 2023Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Covington
Cantor Fitzgerald
Deloitte
Healthtrust
UBS
Queensland Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.